GE HealthCare reported third quarter 2026 revenue of $5.5 billion, up 7.2%, and net income attributable to the company of $615 million versus $446 million a year earlier. The company raised its full-year 2026 adjusted EPS guidance to $4.95 to $5.05, and also disclosed that Jeannette Bankes, President and CEO of Patient Care Solutions, will resign effective November 15, 2026, with Neal Sandy succeeding her on November 16.
Q3 2026 revenue of $5.5 billion, up 7.2% (organic growth 6.2%); diluted EPS of $1.36 versus $0.98; adjusted EPS of $1.34 versus $1.07
Full-year 2026 adjusted EPS guidance raised to $4.95 to $5.05, from $4.80 to $5.00; organic revenue growth now about 4.0%
Jeannette Bankes to resign as President and CEO, Patient Care Solutions, with last day November 15, 2026; Neal Sandy to become President and CEO on November 16, 2026
Company plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expected to close in the first half of 2027
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From GE HealthCare's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$20.62B
+4.8%
$4.55
+4.8%
10.1%
FY2024
$19.67B
+0.6%
$4.34
+43.2%
10.1%
FY2023
$19.55B
+6.6%
$3.03
-28.2%
8.0%
FY2022
$18.34B
+4.3%
$4.22
-14.7%
10.4%
FY2021
$17.59B
—
$4.95
—
12.8%
Frequently asked questions
When is GE HealthCare's next earnings date?
GE HealthCare has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did GE HealthCare earn last quarter?
For the quarter ended Sep 2026, GE HealthCare reported diluted EPS of $1.36 (+38.8% year over year) on revenue of $5.51B (+7.2%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.